INTREXON CORP (XON) has 70 open-market insider trades by 19 insiders since 2013. The most active filer is Randal J. Kirk, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Randal J. Kirk | CEO | — | 38 | $312.0M | 2020-01-04 |
| Gregory Ian Frost | SVP--Health Sector | — | 1 | $2.6M | 2015-05-28 |
| Joel D. Liffman | VP | — | 2 | $1.4M | 2019-01-04 |
| Thomas D. Reed | CSO | — | 4 | $1.2M | 2020-01-06 |
| Krish S. Krishnan | COO | — | 2 | $1.0M | 2016-01-29 |
| Suma Krishnan | SVP--Product Development | — | 2 | $1.0M | 2016-01-29 |
| Jeffrey B. Kindler | Dir | — | 2 | $727K | 2019-03-23 |
| Robert B. Shapiro | Dir | — | 2 | $530K | 2019-03-23 |
| Nir Nimrodi | VP | — | 3 | $335K | 2019-01-04 |
| Thomas R. Kasser | SVP--Food Sector | — | 2 | $214K | 2014-05-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Donald P. Lehr | CLO | Sell | $42K | 2020-01-06 |
| Thomas D. Reed | Chief Science Officer | Sell | $32K | 2020-01-06 |
| Helen Sabzevari | President | Sell | $39K | 2020-01-06 |
| Thomas Bostick | COO | Sell | $38K | 2020-01-06 |
| Rick L. Sterling | CFO | Sell | $21K | 2020-01-03 |
| Donald P. Lehr | CLO | Sell | $22K | 2020-01-03 |
Companies that share insiders with XON, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Thomas D. Reed | Chief Science Officer | Sell | $17K | 2020-01-03 |
| Rick L. Sterling | CFO | Sell | $24K | 2020-01-02 |
| Thomas D. Reed | Chief Science Officer | Sell | $20K | 2020-01-02 |
| Helen Sabzevari | President | Sell | $27K | 2020-01-02 |
| Thomas D. Reed | Chief Science Officer | Sell | $20K | 2019-10-01 |
| Helen Sabzevari | President & Precigen +1 | Sell | $28K | 2019-10-01 |
| Rick L. Sterling | CFO | Sell | $25K | 2019-10-01 |
| Donald P. Lehr | CLO | Sell | $28K | 2019-10-01 |
| Helen Sabzevari | President | Sell | $127K | 2019-07-18 |